TY  - JOUR
AU  - Karachaliou, Niki
AU  - Gonzalez-Cao, Maria
AU  - Crespo, Guillermo
AU  - Drozdowskyj, Ana
AU  - Aldeguer, Erika
AU  - Gimenez-Capitan, Ana
AU  - Teixido, Cristina
AU  - Angel Molina-Vila, Miguel
AU  - Viteri, Santiago
AU  - De los Llanos Gil, Maria
AU  - Martin Algarra, Salvador
AU  - Perez-Ruiz, Elisabeth
AU  - Marquez-Rodas, Ivan
AU  - Rodriguez-Abreu, Delvys
AU  - Blanco, Remedios
AU  - Puertolas, Teresa
AU  - Angeles Royo, Maria
AU  - Rosell, Rafael
PY  - 2018
DO  - 10.1177/1758834017749748
SN  - 1758-8340
UR  - https://hdl.handle.net/10668/26708
T2  - Therapeutic advances in medical oncology
AB  - Background: Programmed death-ligand 1 (PD-L1) may be induced by oncogenic signals or can be upregulated via interferon gamma (IFN-gamma). We have explored whether the expression of IFNG, the gene encoding IFN-gamma, is associated with clinical...
LA  - en
PB  - Sage publications ltd
KW  - Immunotherapy
KW  - interferon-gamma
KW  - PD-1
KW  - PD-L1
KW  - lung cancer
KW  - melanoma
KW  - Pd-1 blockade
KW  - Open-label
KW  - Ifn-gamma
KW  - T-cells
KW  - Clinical-response
KW  - Ctla-4 blockade
KW  - Viral mimicry
KW  - Double-blind
KW  - Expression
KW  - Chemotherapy
TI  - Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
TY  - research article
VL  - 10
ER  -